Allegan County reaffirms support for Palisades restart. Where do efforts stand?
Holtec International still awaits official approval from the United States Nuclear Regulatory Commission to re-open Palisades Nuclear Power Plant. In the meantime, local elected officials have reiterated their support for the project.
Holtec is seeking regulatory approval to restart power operations at Palisades after the plant closed for decommissioning in May 2022. A federal loan of $1.52 billion was approved for the project in 2024, but the NRC has yet to officially approve the restart.
During a meeting June 12, the Allegan County Board of Commissioners unanimously approved a resolution to 'reaffirm support' for the re-opening of Palisades. The board passed a similar resolution in January 2023.
The resolution includes several points Holtec has made regarding the restart, including the benefits of job creation, grid stability and reliability, and clean energy.
According to the NRC, approval is necessary to restore the plant's license for operational status, but is also needed before Holtec can ready plant components or make any needed upgrades or repairs.
Holtec has previously requested the NRC make a determination this summer, in hopes of resuming power operations in the fourth quarter of 2025.
Most recently, Holtec announced the NRC issued a Final Environmental Assessment and Finding of No Significant Impact for Palisades. The ruling found 'the project poses no significant environmental risk,' Holtec wrote in an update.
Holtec also said an Initial Licensed Operator Class is on-track for NRC examination in June, which will add 26 federally licensed operators to the site. A separate class is underway and scheduled for testing in early 2026.
In late May, Palisades received full accreditation for its maintenance and technical training program, completing the "complement of accreditations' required for operation.
Two emergency preparedness exercises have been completed at Palisades, with more scheduled for this summer. The drills will culminate in a graded exercise evaluated by the NRC and FEMA.
Earlier this year, a coalition of environmental groups and a group of residents living near Palisades filed petitions with the NRC's Atomic Safety and Licensing Board in an effort to stop or delay the restart. In March, the board denied requests for full hearings on the petitions.
More: 'Not admissible': Request for formal hearing challenging Palisades re-opening denied
Palisades ceased power operations in May 2022, and was sold to Holtec for decommissioning shortly after. Just a few months later, a plan to restart the plant was announced. An initial funding request was denied, but a second effort was launched early in 2023.
Holtec is also seeking to build two small modular reactors, SMR-300s, at Palisades, which would add at least 600 megawatts to the plant's 800-megawatt generating capacity. Preliminary activities are underway and Holtec plans to file a construction permit application for the SMRs in 2026.
There are currently no upcoming meetings scheduled for the Palisades restart, per the NRC website. Learn more about regulatory actions and upcoming meetings at nrc.gov/info-finder/reactors/pali.html.
— Contact reporter Mitchell Boatman at mboatman@hollandsentinel.com.
This article originally appeared on The Holland Sentinel: Allegan County reaffirms support for restart at Palisades Plant
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
21 hours ago
- Yahoo
National Research Solidifies Dividend Amid Insider Buying and Contract Growth
National Research Corporation (NASDAQ:NRC) is one of the 10 low risk dividend paying stocks for June 2025. The company has reported a sequential increase in total recurring contract value, which is followed by a notable change in insider activity. A healthcare professional using a digital device to provide a health risk assessment to a patient. National Research Corporation (NASDAQ:NRC), carrying on business operations as NRC Health, is a healthcare organization based in Nebraska. With their subscription-based solutions, the company offers analytics and insights that enable healthcare organizations to improve patient and employee experience. The focus of the solutions is aimed at various aspects of the company's operations, including patient satisfaction, staff retention, and brand perception. National Research Corporation (NASDAQ:NRC) reported its Q1 results for 2025, earlier this May, in which it reported a sequential increase in total recurring contract value. With this growth, the company recorded a notable milestone in its revenue growth strategy. Following the announcement, on May 12, 2025, Patrick Beans, a significant shareholder, acquired an additional 2,500 shares of the company's common stock in a transaction valued at $33,973. The company offers a dividend yield of 2.90%, with a beta of 0.39, signaling its limited volatility to the market changes. The ex-dividend date is June 27, 2025, and investors seeking to benefit from the next payout should purchase the stock before the date. While we acknowledge the potential of NRC as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and . Disclosure. None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
2 days ago
- Yahoo
Citi Starts Coverage of NuScale Power (SMR) Stock, Gives Neutral
NuScale Power Corporation (NYSE:SMR) is one of the 10 Unstoppable Stocks to Buy According to Hedge Funds. On June 23, Citi analyst Vikram Bagri began coverage of the company's stock with a 'Neutral' rating and a price objective of $46. The company possesses a first-mover advantage in the industry, which is aided by increased power demand due to the data centers and AI. A Nuclear power plant with all its safety & security protocols in place. Notably, NuScale Power Corporation (NYSE:SMR)'s unrated and approved 77 MW design, modular technology, relationship with Fluor, supply chain partnerships, and no HALEU dependence place it well amidst competition, while new contract announcements remain on the horizon, added the analyst. However, it was also pointed out that significant execution risks are there, while the stock appears to be pricing nearly 50 GW of installs by 2040, added Bagri. NuScale Power Corporation (NYSE:SMR) announced that it has received design approval from the US Nuclear Regulatory Commission for the uprated 250 MWt (77 MWe) NuScale Power Modules. In Q1 2025, the company's revenue rose $12.0 million to $13.4 million compared to $1.4 million. This rise was due to revenues generated from FEED Phase 2 project as well as the Technology License Agreement for the RoPower Doicești power plant. While we acknowledge the potential of SMR to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than SMR and that has 100x upside potential, check out our report about this cheapest AI stock. READ NEXT: 13 Cheap AI Stocks to Buy According to Analysts and 11 Unstoppable Growth Stocks to Invest in Now Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
2 days ago
- Yahoo
NuScale (SMR) Drops by Double Digits on Analyst Downgrade
We recently published . NuScale Power Corporation (NYSE:SMR) is one of the worst-performing stocks on Wednesday. NuScale Power dived by 10.59 percent on Wednesday to end at $38.66 apiece as investor sentiment was dampened by an investment company's downgrade of its stock to 'neutral' from 'buy.' In its market note, BTIG said its revision was based on NuScale Power Corporation's (NYSE:SMR) limited visibility into orderbook growth, coupled with a stretched valuation following a sharp rally in its share price. Year-to-date, NuScale Power Corporation (NYSE:SMR) already saw a 118.29-percent increase in its share prices, while the past year alone saw a 252.42-percent rally in its stock. In recent news, NuScale Power Corporation (NYSE:SMR) joined forces with Paragon Energy Solutions to support the expansion of the nuclear industry. A Nuclear power plant with all its safety & security protocols in place. Under the signed strategic agreement, Paragon Energy will supply NuScale Power Corporation (NYSE:SMR) with its CoreVision Neutron Monitoring System technology and its Highly Integrated Protection System (HIPS), which will then be incorporated into ENTRA1 Energy PlantsTM utilizing NuScale SMR technology. While we acknowledge the potential of SMR as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires. Disclosure: None. This article is originally published at Insider Monkey.
